Posted by Michael Wonder on 21 Mar 2019
Is Orkambi deal close? Vertex meets again today with NHS England
21 March 2019 - Campaigners hopes rise after three year wait.
A breakthrough in the long-running dispute over Vertex’s cystic fibrosis drug Orkambi could be within sight, as the company meets again today with NHS England and NICE.
It has been three years since Orkambi was approved in Europe, but for much of that time Vertex has been at loggerheads with England’s cost effectiveness watchdog NICE and NHS England about the price of the drug.
